Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [A rare cause of acute heart failure? : Aorto-right atrial fistula!] | Inn Med (Heidelb) | 2023 | 37272988 | PubTator, text mining | PubMed |
| RAS-targeted cancer therapy: Advances in drugging specific mutations. | MedComm (2020) | 2023 | 37250144 | PubTator, text mining | PubMed |
| Vulvar Langerhans cell histiocytosis: Clinicopathologic characteristics, mutational profile, and treatment of 4 patients in a single-center cohort. | JAAD Case Rep | 2023 | 37250013 | PubTator, text mining | PubMed |
| Proteomic Signature of Extracellular Vesicles Associated with Colorectal Cancer. | Molecules | 2023 | 37241967 | PubTator, text mining | PubMed |
| Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer-A Nation-Wide Study. | Int J Mol Sci | 2023 | 37240418 | PubTator, text mining | PubMed |
| Loss of Primary Cilia Potentiates BRAF/MAPK Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (CROCC) Alterations. | Genes (Basel) | 2023 | 37239344 | PubTator, text mining | PubMed |
| Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases. | Neuroendocrinology | 2023 | 37232011 | PubTator, text mining | PubMed |
| Understanding and targeting resistance mechanisms in cancer. | MedComm (2020) | 2023 | 37229486 | PubTator, text mining | PubMed |
| Role of Molecular Targeted Therapeutic Drugs in Treatment of Breast Cancer: A Review Article. | Glob Med Genet | 2023 | 37228871 | PubTator, text mining | PubMed |
| The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. | Theranostics | 2023 | 37215575 | PubTator, text mining | PubMed |
| Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A. | J Cancer | 2023 | 37215441 | PubTator, text mining | PubMed |
| New small molecules in dermatology: for the autoimmunity, inflammation and beyond. | Inflamm Res | 2023 | 37212867 | PubTator, text mining | PubMed |
| Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. | Explor Target Antitumor Ther | 2023 | 37205308 | PubTator, text mining | PubMed |
| Expression and Clinical Correlation of PD-1/PD-L1 and VE1(BRAFp.V600E) in Pediatric Langerhans Cell Histiocytosis. | Mediterr J Hematol Infect Dis | 2023 | 37180201 | PubTator, text mining | PubMed |
| Non-small-cell lung cancer: how to manage BRAF-mutated disease. | Drugs Context | 2023 | 37168877 | PubTator, text mining | PubMed |
| BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience. | Front Oncol | 2023 | 37124503 | PubTator, text mining | PubMed |
| Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy. | Front Oncol | 2023 | 37124491 | PubTator, text mining | PubMed |
| Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression. | Asian Pac J Cancer Prev | 2023 | 37116161 | PubTator, text mining | PubMed |
| Selected Approaches to Disrupting Protein-Protein Interactions within the MAPK/RAS Pathway. | Int J Mol Sci | 2023 | 37108538 | PubTator, text mining | PubMed |
| Promoted Skin Wound Healing by Tail-Amputated Eisenia foetida Proteins via the Ras/Raf/MEK/ERK Signaling Pathway. | ACS Omega | 2023 | 37091432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=11